Endothelial Regulation of Fibrinolytic Activity

The vascular endothelium plays a central role in maintaining haemostatic balance by orchestrating the activation and inhibition of fibrinolysis. Endothelial cells synthesise and release plasminogen activators, notably tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), which convert plasminogen to plasmin, initiating clot dissolution. Concurrently, they produce key inhibitors such as plasminogen activator inhibitor-1 (PAI-1) that restrain plasmin generation and stabilise thrombi when necessary. Endothelial fibrinolytic activity is modulated by mechanical forces (for example shear stress), circulating hormones, growth factors and inflammatory mediators, enabling rapid adaptation to physiological and pathological stimuli. The precise localisation of activators and inhibitors at the cell surface or within specialised storage granules ensures spatially restricted fibrinolysis, critical for vascular integrity. Dysregulation of this system contributes to thrombotic disorders, atherosclerosis and impaired tissue repair. Understanding endothelial control of fibrinolysis has underpinned the development of thrombolytic therapies, endothelial graft design and novel approaches to vascular inflammation management.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Endothelial Regulation of Fibrinolytic Activity publication trend

The graph below shows the total number of articles in endothelial regulation of fibrinolytic activity across all publications each year (not limited to Nature Index journals).

Technical terms

Endothelium: The monolayer of cells lining the interior surface of blood vessels, regulating vascular tone and haemostasis.

Fibrinolysis: The enzymatic process that degrades fibrin clots, primarily mediated by plasmin.

Tissue-type plasminogen activator (tPA): An endothelial-derived serine protease that converts plasminogen to plasmin, initiating clot breakdown.

Urokinase-type plasminogen activator (uPA): A circulating or cell-associated enzyme that activates plasminogen, contributing to matrix remodelling and cell migration.

Plasminogen activator inhibitor-1 (PAI-1): A primary inhibitor of tPA and uPA, controlling the onset and extent of fibrinolysis.

Lipopolysaccharide (LPS): A bacterial cell-wall component that triggers endothelial inflammatory responses, influencing fibrinolytic balance.

References

1. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.. Journal of Biological Chemistry (1984).
2. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.. Journal of Biological Chemistry (1988).
3. Regulation of Type 1 Plasminogen Activator Inhibitor Gene Expression in Cultured Bovine Aortic Endothelial Cells Induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-α. Journal of Biological Chemistry (1989).
4. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.. Journal of Biological Chemistry (1988).
5. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.. Journal of Biological Chemistry (1984).